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Side effectClassic antidepressants have been known to induce convulsive seizures and nonconvulsive status epilepticus
(NCSE). On the other hand, many reports have emphasized the safety of novel antidepressants. However, we en-
countered three cases of NCSE in the elderly associated with the use of newer antidepressants at therapeutic
doses.
All three patients were male and were 73 years of age or older. One patient was recently diagnosed with tempo-
ral lobe epilepsy and treatedwith low-dose lamotrigine. In all patients, newer antidepressants were initiated be-
cause of depressive symptoms. After titrating to therapeutic doses (paroxetine 20 mg/day, sertraline 50 mg/day,
and combination of sertraline 50 mg/day and mirtazapine 30 mg/day in one patient each), impaired conscious-
ness appeared. Electroencephalography (EEG) showed generalized slow waves with intermittent spike–slow-
wave complexes. Intravenous injection of antiepileptic drugs improved EEG ﬁndings and clinical symptoms.
After discontinuance of the abovementioned antidepressants, NCSE did not recur in any of patients. These reports
raise the question of whether the newer antidepressants, like classic antidepressants, might also induce NCSE in
the elderly, evenwhen used at therapeutic doses. Physicians should considermonitoring for possible NCSEwhen
using newer antidepressants in patients whomay have low drug tolerability. Active continuous video-EEGmon-
itoring is essential when behavioral and psychological symptoms or change in consciousness level is suspected.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Nonconvulsive status epilepticus (NCSE) is clinically diagnosed as a
prolonged epileptic condition with diminished level of consciousness
and behavioral and/or mental abnormalities, but without major
convulsive movements, accompanying epileptiform discharges onviously reported in Japanese in
c., 2007; 25: 10–15.
of both journals.
ry, National Center Hospital of
aira, Tokyo 187-8551, Japan.
hi).
. This is an open access article underelectroencephalography (EEG) [1,2]. Nonconvulsive status epilepticus
may occur not only in patients with epilepsy but also in adults with
no previous history of epilepsy [1,2]. According to some reports, a num-
ber of medications including cephalosporins, ﬂuoroquinolones, penicil-
lins, and psychotropics may induce NCSE [2–5].
Classic antidepressants have been known to induce NCSE and con-
vulsive seizures [3,4]. On the other hand, many reports have empha-
sized the safety of novel antidepressants such as selective serotonin
reuptake inhibitors (SSRI), serotonin and norepinephrine reuptake in-
hibitors (SNRI), and noradrenergic and speciﬁc serotonergic antidepres-
sants (NaSSA) [6–8]. However, we encountered three cases of NCSE in
the elderly associated with the use of newer antidepressants (paroxe-
tine, sertraline, and mirtazapine) at therapeutic doses. We, therefore,
reviewed the safety of antidepressant use in the elderly with respect
to convulsive seizures and NCSE.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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2.1. Case 1 (this case report is based on a case report ﬁrst reported in J. Jpn.
Epil. Soc., 2007; 25: 10–15 in Japan)
A 76-year-old, previously neurologically healthy man with depres-
sion was treated with paroxetine 10 mg/day combined with quazepam
15 mg/day and alprazolam 1.2 mg/day. Two days after the paroxetine
dose was increased to 20 mg/day, tremor of both upper limbs and epi-
sodic disturbance of consciousness accompanying impaired dexterity
occurred. Conventional EEG recording showed frontal-dominant gener-
alized slow-spike and slow-wave complexes on EEG, correlating with
impaired consciousness (Fig. 1a). After intravenous injection of 2.5 mg
of diazepam (DZP), spike–slow-wave complexes disappeared, and
clinical symptoms were ameliorated (Fig. 1b). After paroxetine
was discontinued, treatment with phenytoin (PHT) resulted in com-
plete resolution of the disturbed consciousness and abnormal EEG,
and these symptoms did not recur even after PHT was tapered and
discontinued. We diagnosed this case as paroxetine-induced NCSE.
During follow-up for 7 years, he has never had a relapse of NCSE.
2.2. Case 2 (this case is based on a case report ﬁrst reported in Jpn. J.
Psychiatr. Treat., 2013; 28: 365–372 in Japan)
A 73-year-oldmanwith depression had a history of anxiety disorder
since 69 years of age. Combination therapy of sertraline 50 mg/day and
mirtazapine 15 mg/day was started for hypochondriac symptoms and
severe insomnia. Five days after titrating the mirtazapine dose to
30 mg/day, his family noticed that he responded poorly to conversation
and occasionally stopped duringmovement with a vacant stare. At pre-
sentation to the emergency room, examination showed disturbed con-
sciousness, myoclonus, and tremor resembling catatonic symptoms.
Conventional EEG demonstrated generalized slowwaveswith intermit-
tent spike and slow-wave complexes. Intravenous injection of 5 mg of
DZP improved EEG ﬁndings and resolved clinical symptoms. Because
the effect of DZP was transient and the catatonic symptoms recurred,
he was admitted to our hospital. After admission, long-term video-
EEG recording was started, which showed continuous slow background
activity and generalized, frontally predominant spike or polyspike-and-
wave discharges during a catatonic episode (Fig. 1c). We obtained new
information that he developed the same symptoms while takingFig. 1. Electroencephalograms (EEG) before and after treatment with antiepileptic drug treatm
altered state of consciousness. Spike and slow-wave complexes are observed. (b) Case 1 record
slow-wave complexes are no longer observed. (c) Case 2 while on sertraline 50 mg/day and m
background activity and generalized, frontally predominant spike or polyspike-and-wave disch
tiform discharges are no longer observed.amitriptyline 100 mg/day at the age of 69, albeit acting via a different
neurotransmitter mechanism, which supports a diagnosis of NCSE trig-
gered by antidepressant. Nonconvulsive status epilepticus was
completely resolved with intravenous injection of phenobarbital
750 mg (Fig. 1d). Sertraline and mirtazapine were tapered and
discontinued. The antiepileptic drug (AED) was then discontinued,
and there has been no relapse during follow-up for 2 years.
2.3. Case 3
A 76-year-oldman had onset of seizures at the age of 73, but the sei-
zures were not evaluated, and hewas treated for dementia. He present-
ed at our hospital at the age of 76. Detailed clinical examinations and
EEG led to a diagnosis of temporal lobe epilepsy. He was admitted to
our hospital because of severe depressive symptoms. During titration
of lamotrigine (LTG), depression deteriorated, and suicidal ideation
also increased. Therefore, sertraline 25 mg/daywas started. After titrat-
ing the sertraline dose to 50 mg/day combinedwith LTG 25 mg/day and
nitrazepam 5 mg/day, he became markedly anorexic and appeared
dazed, and his movements became more sluggish than usual. These
symptoms suggested aggravated depressive symptoms. Two days after
the sertraline dose was increased, EEG was obtained for differential di-
agnosis and revealed irregular unsteady alpha rhythms. The next day,
EEG was performed again as the ﬁnal screening for electroconvulsive
therapy, which showed frontal, right temporal-dominant slow-wave
rhythm gradually increasing in amplitude to form slow waves and
spikes. Correlating with EEG changes, the level of cognition ﬂuctuated
between reduced awareness and complete unresponsiveness. His
movements stoppedwhen high-voltage slowwaves and spikes became
diffuse.
Intravenous DZP temporarily normalized the EEG ﬁndings and level
of consciousness. The patient was diagnosed with NCSE (and electro-
convulsive therapy was canceled), and he was monitored carefully
with long-term video-EEG (Fig. 2).
Two days after sertraline was discontinued, clinical symptoms
and EEG ﬁndings were resolved, while the LTG dose was increased to
200 mg/day for the purpose of treating his depressive mood. However,
approximately one month after that episode, his depression worsened.
The patient was treated with intravenous infusion of clomipramine
25 mg and oral mirtazapine 15 mg. Under careful observation, NCSE
did not relapse, and depressive symptoms were ameliorated.ent in Cases 1 and 2. (a) Case 1 while on paroxetine 20 mg/day. EEG was recorded during
ed approximately 170 s after starting intravenous injection of 2.5-mg diazepam. Spike and
irtazapine 30 mg/day. EEG was recorded during a catatonic-like episode. Continuous slow
arges are observed. (d) Case 2 after intravenous injection of 750-mg phenobarbital. Epilep-
Fig. 2.Color density spectral array (CDSA) for the EEGdata of Case 3. On theCDSA, time is shownon theX axis and frequency (range: 0 to 20Hz) on the Y axis. The frequency-speciﬁc power
from 0 to 3.5 Hzwas visually represented using a color scale, with blue representing low power and light blue, green, yellow, and red representing successively higher power. In this case,
seizure activity (emphasized in square) typically lasts 8–10 min and recurs every 30–50 min.
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3.1. NCSE precipitated by antidepressants
We have presented three cases of elderly menwith NCSE associated
with the newer antidepressants at therapeutic doses. Most anti-
depressants are considered to have a propensity to lower the seizure
threshold. Classic antidepressants (clomipramine, maprotiline,
bupropion, mianserine, and amitriptyline) are known to induce NCSE
and convulsions in some patients [2–5]. By contrast, a PubMed search
found only a few case reports of seizures associated with newer antide-
pressants [9–11]. To the best of our knowledge, this is the ﬁrst case re-
port of proven NCSE associated with the newer antidepressants.
People with epilepsy are well known to have a high rate of depres-
sive symptoms [8]. Moreover, the presence of depressive symptoms
mayhave a greater adverse effect than epileptic seizures on the patient's
quality of life [12]. Therefore, there is growing interest regarding depres-
sion in peoplewith epilepsy. As a result, an increasing number of reports
support the view that patients with epilepsy with depression should be
treated activelywith antidepressants [7,8]. Considering the effect on sei-
zure threshold, these reports recommend novel antidepressants such as
SSRIs, SNRIs, and NaSSAs instead of classic agents such as tricyclic
antidepressants [7,8]. Furthermore, a report even proposed that novel
antidepressants possess anticonvulsant rather than proconvulsant
actions [6].
However, in the absence of reports evaluating the seizure threshold
in clinical studies of elderly patients or using aged animal models, the
safety of novel antidepressants regarding their effects on epileptic sei-
zure threshold in the elderly remains debatable. Currently, it is consid-
ered desirable to use these newer agents with caution. This view issupported by a cohort study investigating the safety of antidepressants
for treating depression in elderly patients, which has indicated that
newer antidepressants are not necessarily safer than classic agents [13].
3.2. Difﬁculty in diagnosing NCSE in elderly patients
The diagnosis of NCSE is particularly challenging in elderly patients
because clinical symptoms may be very subtle and, sometimes, difﬁcult
to differentiate from usual behaviors or psychiatric disorders [1].
Furthermore, many elderly persons already have comorbidities that
cause “stupor”, “amnesia”, “delirium”, and “confusional episodes”. In par-
ticular, concurrent psychiatric diseases such as depression and dementia
may complicate the diagnosis [1,14]. As there are no speciﬁc clinical and
radiographic ﬁndings for NCSE, a diagnosis often relies on EEG ﬁndings
[2]. A standard routine EEG may not always detect NCSE because of the
variability of electrographic seizure patterns. Electrographic and clinical
seizure activity may occur not only continuously but also intermittently
[15]. As Fig. 2 illustrates (Case 3), some types of NCSE in older patients
occur at relatively constant intervals. Additionally, postictal confusion
lasts for 1–2 h or occasionally longer in an elderly patient without any
other clinical signs suggestive of NCSE. Therefore, the rate of diagnosis
of NCSE might be increased greatly if continuous video-EEG monitoring
were used in suspected cases. The analysis of such monitoring can be fa-
cilitated by techniques such as color density spectral array (CDSA), also
termed a color spectrogram, which is a quantitative EEG display tool
that permits easy recognition of NCSE in prolonged EEG recording. In
CDSA, fast Fourier transformation (FFT) is used to convert raw EEG into
a time-compressed and color-coded display.
As shown in Fig. 2 and illustrated in the report of Friedman et al. [15],
CDSA is a useful tool for identiﬁcation of NCSE in older patients.
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probably underrecognized in clinical practice. Delay in NCSE diagnosis
and prolonged seizure activity may lead to aspiration pneumonia, falls,
and other accidents,which are associatedwith increasedmortality [2,14].
4. Conclusion
Like classic antidepressants, newer antidepressants also may be
associated with NCSE in the elderly, even when used at therapeutic
doses. In view of the apparent association between NCSE and the com-
mencement of newer antidepressant drugs that has been illustrated by
these three case reports, it is recommended that when suchmedication
is commenced in the elderly, that the patient be monitored closely for
impaired awareness and, if this is observed, that EEGmonitoring be per-
formed to determine whether this is attributable to NCSE.
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